ClinicalTrials.govpublic full text
Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease
non-alcoholic fatty liver disease, fatty liver, nonalcoholic, nafld, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, nash, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1010941
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.